Table 1

Demographic characteristics of study participants

CharacteristicTotal (n=181)Controls (n=127)BeS* (n=35)CBD (n=19)
Gender, n (%)
 Male164 (91%)116 (91%)31 (89%)17 (89%)
 Female17 (9%)11 (9%)4 (11%)2 (11%)
Race, n (%)
 White174 (96%)124 (98%)34 (97%)16 (84%)
 African-American7 (4%)3 (2%)1 (3%)3 (16%)
Smoking status, n (%)
 Never78 (43%)57 (45%)13 (37%)8 (42%)
 Former91 (50%)61 (48%)19 (54%)11 (58%)
 Current12 (7%)9 (7%)3 (9%)0 (0%)
Work status, n (%)
 Current worker85 (47%)58 (46%)15 (43%)12 (63%)
 Former worker96 (53%)69 (54%)20 (57%)7 (37%)
Median age (range)62 (30–87)63 (30–87)62 (41–87)58 (48–81)
Median year of hire (range)1970 (1947–2001)1969 (1947–2001)1972 (1950–1998)1970 (1958–1985)
Median years at Y-12 (range)25 (<1–47)24 (<1–47)19 (3–40)22 (2–31)
Median number of job titles (range)2 (1–7)2 (1–5)3 (1–5)2.5 (1–5)
Median number of beryllium exposure tasks (range)2 (0–8)1 (0–4)2 (1–5)§2 (0–5)
  • * Includes 15 without a full medical evaluation to exclude CBD.

  • p<0.05 versus controls (Fisher's exact test).

  • p<0.05 versus controls (Wilcoxon rank sum).

  • § p<0.05 versus BeS (Wilcoxon rank sum).

  • BeS, beryllium sensitisation; CBD, chronic beryllium disease.